09 October,2022 08:18 AM IST | New Delhi | Agencies
Indian authorities are investigating cough syrups made by a local pharma company after WHO linked it with deaths of 66 children in Gambia. Pic/PTI
The WHO's recent alert linking cough syrups manufactured by an Indian pharmaceutical firm to the deaths of 66 children in Gambia is "alarming" and there are some missing links that need to be "investigated", an expert said on Saturday.
The World Health Organisation on Wednesday issued an alert, saying four "contaminated" and "substandard" cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths in the West African nation.
"There are some missing links that need to be carefully ascertained and investigated," said Professor Y K Gupta, senior pharmacologist and vice chairman of the Standing National Committee on Medicines.
"It is important to understand here that only new drug approval is granted by DCGI whereas licence for manufacture and sale is given by state drug controller. In this case, the licence for manufacture and sale was given by the state drug controller. The company was licensed to export only to this one country and not in any other country."
ALSO READ
Mumbai man finds relief from Ankylosing Spondylitis after 30 yrs of chronic pain
India’s B2B2C mental health market likely to reach $3.9 billion by FY29
Consuming too much salt? It's harming your health, say experts
Four children among six injured in attack on Gaza vaccination centre
India has one of the highest levels of treatment coverage for tuberculosis: WHO
Also Read: Mumbai: October sees highest rainfall in decade, IMD issues yellow alert for Monday
The other missing link is that of the 23 samples which were tested by WHO, ethylene glycol was found only in four samples, said Dr Gupta, adding, "This is perplexing and needs clarification." "Also, the importing country gets it tested as per defined standards or their pharmacopoeia. It seems this was somehow missed," he said.
Oct 5
When WHO issued alert against four âsubstandard' cough syrups
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
